|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 38/19 | |||
| A61K 45/00 | |||
| A61K 39/00 |
| (11) | Patento numeris | 1225870 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 00968692.4 |
| Europos patento paraiškos padavimo data | 2000-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2002-07-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2006-12-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2000/027399 |
| Data | 2000-10-05 |
| (87) | Numeris | WO 2001/024771 |
| Data | 2001-04-12 |
| (30) | Numeris | Data | Šalis |
| 412681 | 1999-10-05 | US |
| (72) |
Wood, Gary W., US
|
| (73) |
TVAX Biomedical, LLC,
500 West 112th Street, Kansas, MO 64114,
US
|
| (54) | COMPOSITION AND METHOD OF CANCER ANTIGEN IMMUNOTHERAPY |
| COMPOSITION AND METHOD OF CANCER ANTIGEN IMMUNOTHERAPY |